These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27556883)

  • 1. An Inhaled Inhibitor of Myristoylated Alanine-Rich C Kinase Substrate Reverses LPS-Induced Acute Lung Injury in Mice.
    Yin Q; Fang S; Park J; Crews AL; Parikh I; Adler KB
    Am J Respir Cell Mol Biol; 2016 Nov; 55(5):617-622. PubMed ID: 27556883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARCKS-related peptide modulates in vivo the secretion of airway Muc5ac.
    Foster WM; Adler KB; Crews AL; Potts EN; Fischer BM; Voynow JA
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L345-52. PubMed ID: 20543006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myristoylated alanine-rich C kinase substrate (MARCKS) protein inhibits ozone-induced airway neutrophilia and inflammation.
    Damera G; Jester WF; Jiang M; Zhao H; Fogle HW; Mittelman M; Haczku A; Murphy E; Parikh I; Panettieri RA
    Exp Lung Res; 2010 Mar; 36(2):75-84. PubMed ID: 20205598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils.
    Li J; D'Annibale-Tolhurst MA; Adler KB; Fang S; Yin Q; Birkenheuer AJ; Levy MG; Jones SL; Sung EJ; Hawkins EC; Yoder JA; Nordone SK
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):314-21. PubMed ID: 23221047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury.
    Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY
    Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324
    [No Abstract]   [Full Text] [Related]  

  • 6. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
    Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
    Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
    [No Abstract]   [Full Text] [Related]  

  • 7. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
    Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
    Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
    Zhang A; Wang S; Zhang J; Wu H
    Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
    Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
    Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice.
    Zhang Z; Luo Z; Bi A; Yang W; An W; Dong X; Chen R; Yang S; Tang H; Han X; Luo L
    Eur J Pharmacol; 2017 Sep; 811():1-11. PubMed ID: 28552343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
    Takashima K; Matsushima M; Hashimoto K; Nose H; Sato M; Hashimoto N; Hasegawa Y; Kawabe T
    Respir Res; 2014 Nov; 15(1):150. PubMed ID: 25413579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice.
    Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS
    J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
    Chen XY; Dou YX; Luo DD; Zhang ZB; Li CL; Zeng HF; Su ZR; Xie JH; Lai XP; Li YC
    Int Immunopharmacol; 2017 Sep; 50():270-278. PubMed ID: 28711783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myristoylated alanine-rich C kinase substrate (MARCKS) regulates the expression of proinflammatory cytokines in macrophages through activation of p38/JNK MAPK and NF-κB.
    Lee SM; Suk K; Lee WH
    Cell Immunol; 2015 Aug; 296(2):115-21. PubMed ID: 25929183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
    Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
    Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
    Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
    Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.